Celldex Therapeutics Income Statement
- Quarterly: March 2013 - December 2010 Previous Quarters
- Annual
| Income | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| Revenue | 2.414M | 3.647M | 3.113M | 2.009M | 2.433M | 2.434M | 2.363M | 1.952M | 2.516M | 37.72M |
| Cost of Goods Sold | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 0.0800M | 0.0960M | 0.1070M | 0.1360M | 0.0890M | 0.0760M | 0.0450M | 0.0110M | 0.0140M | 30.92M |
| Amortization Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Depreciation, Amortization, Depletion Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| R&D Expense | 14.09M | 13.75M | 11.77M | 11.11M | 10.77M | 9.824M | 8.594M | 7.169M | 6.853M | 6.742M |
| G&A Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| SG&A Expense | 3.138M | 2.644M | 2.835M | 2.219M | 2.317M | 2.344M | 2.273M | 2.240M | 2.336M | 2.530M |
| Total Operating Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Non-Operating Int Exp | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Special Income and Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Income and Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pre-Tax Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Income from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Income | -17.33M | -16.81M | -15.03M | -13.77M | -13.52M | -12.73M | -11.77M | -10.24M | -10.06M | 22.66M |
| Basic EPS | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| EPS Basic from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Basic | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Diluted EPS | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| EPS Diluted from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Diluted | -0.2300 | -0.2686 | -0.25 | -0.2300 | -0.2700 | -0.2879 | -0.2700 | -0.2700 | -0.3100 | 0.7074 |
| Shares Data | 2013-03 | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 |
| Average Basic Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Diluted Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
